Diabetes and Insulin- physiology focus Flashcards

1
Q

what do islet of langerhan secrete into circulation

A

insulin (beta cells), glucagon (alpha cells), somatostatin (delta cells), pancreatic polypeptide (PP cells)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

glucagon purpose

A

regulates carbohydrate, fat, protein metabolism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

insulin purpose

A

regulates carbohydrate, fat, protein metabolism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

somatostatin purpose

A

suppresses growth hormone release

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

pancreatic polypeptide purpose

A

self-regulate pancreatic secretion activities (endocrine and exocrine)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

insulin daily levels, half life, metabolism, binding site

A

daily 40-50 units secreted
t1/2 5min
metabolism: liver and kidneys (80%)
binds to extracellular alpha subunits, intracellular beta subunits

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

insulin MOA

A

binds to extracellular domain -> conformational change of alpha subunits -> facilitates ATP binding to beta subunits ->phosphorylation ->mediates enzyme activation, inactivation and metabolic signaling

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

insulin genetic makeup

A

51 amino acid peptide hormone synthesized in beta cells of islets of langerhans as single polypeptide proinsulin, precursor molecule to insulin. proinsulin converted to insulin and c peptide.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what reflects functional activity of pancreatic beta cells

A

plasma concentrations of insulin and c peptide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

glucagon stimulates and inhibits

A

stimulates glycogenolysis (breakdown of glucose) and gluconeogenesis (glucose formation) and inhibits glycolysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

insulin released in response to

A

beta adrenergic stimulation or acetylcholine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what stimulates insulin release (drugs and metabolic environments)

A

hyperglycemia, beta agonists, acetylcholine, glucagon

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what inhibits insulin release (drugs and metabolic environments)

A

hypoglycemia, beta antagonists, alpha agonists, somatostatin, diazoxide, thiazide diuretics, volatile anesthetics, insulin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

glucagon

A

catabolic hormone that mobilizes fatty acids, amino acids into systemic circulation. principle stimulation for secretion is hypoglycemia. activates adenylate cyclase for cAMP formation. exogenous admin can lead to enhanced myocardial contractility. elimination t 1/2 3-6min

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

IV Insulin t1/2, metabolism, renal considerations

A

elimination t1/2 5-10min
metabolized in kidneys and liver by proteolytic enzyme. 50% of insulin that reaches liver through portal vein is metabolized.
renal dysfx alters circulating insulin levels more than hepatic disease.
peripheral tissue (skeletal, muscle, fat) can bind to, inactivate insulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

insulin SQ duration

A

30-60min (tightly bound to tissue receptors).

17
Q

insulin anesthetic implications

A

preoperative morbidity related to preexisting end organ damage
preop chest X-ray may show cardiac enlargement, pulmonary vascular congestion, pleural effusion
increased incidence of ST segment or T wave abnormalities
myocardial ischemia or old infarction may be found on ECG
DM + HTN = 50% likelihood of diabetic autonomic neuropathy
periop CV problems increased with use of ACEI or ARB
diabetic renal dysfx: elevated creatinine and CKD

18
Q

gastroparesis and insulin anesthetic implications

A

premedicate with nonparticulate acid and metoclopramide. risk factors, old age, DM for greater than 10 years, CAD, BB

19
Q

glycolysation implication

A

implies limited mobility of joints, ask them to perform the prayer sign. temporomandibular joint and cervical spine mobility should be assessed preoperatively in diabetic patients to assess for risk of difficult intubation

20
Q

hyperglycemia anesthetic implications

A

associated with hyperrosmolarity, infection, poor wound healing, increased mortality.

21
Q

anesthesia management of diabetic patients

A

patient takes 2/3 of nighttime insulin (NPH, regular) and 1/2 total morning insulin dose of NPH but regular insulin dose for AM should be held
pump: decrease overnight rate by 30% and keep at basal rate for DOS
if patient takes glargine and lispro/aspart daily, take 2/3 glargine dose and entire lispro/aspart night before. hold AM dosing.
add regular insulin to NS in 1 unit/ml conc and begin at .2-1units/kg/hour. target <180mg/dL

22
Q

how to calculate intraop insulin rate

A

regular insulin units/hour = plasma glucose/150

23
Q

1 unit of insulin usually lowers plasma glucose by

A

25-30mg/dL

24
Q

anesthesia management: sulfonylureas and metformin

A

have long half lives, d/c 24-48h before surgery